Comparison of Integrated Positron Emission Tomography/Computed Tomography and Mediastinoscopy in Mediastinal Staging of Non-Small Cell Lung Cancer: Analysis of 212 Patients

References

• Cerfolio R. J., Ojha B., Bryant A. S., Raghuveer V., Mountz J. M., Bartolucci A. A. The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with non-small cell lung cancer. Ann Thorac Surg, 2004, 78: 1017–1023.
   Google Scholar
• Lardinois D., Weder W., Hany T. F. et al. Staging of non-small cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med, 2003, 348: 2500–2507.
   Google Scholar
• Turkmen C., Sonmezoglu K., Toker A. et al. The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high. Clin Nucl Med, 2007, 32: 607–612.
   Google Scholar
• Takamochi K., Yoshida J., Murakami K. et al. Pitfalls in lymph node staging with positron emission tomography in non-small cell lung cancer patients. Lung Cancer, 2005, 47: 235–242.
   Google Scholar
• Raviglione M. C., Snider D. E. Jr., Kochi A. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA, 1995, 273: 220–226.
   Google Scholar
• Detterbeck F. C., Jantz M. A., Wallace M., Vansteenkiste J., Silvestri G. A. Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest, 2007, 132: 202–220.
   Google Scholar
• De Leyn P., Lardinois D., Van Schil P. E. et al. ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer. Eur J Cardiothorac Surg, 2007, 32: 1–8.
   Google Scholar
• GraeterT. P, Hellwig D., Hoffmann K., UkenaD., Kirsch C. M., Schafers H. J. Mediastinal lymph node staging in suspected lung cancer: comparison of positron emission tomography with F-18-fluorodeoxyglucose and mediastinoscopy. Ann Thorac Surg, 2003, 75: 231–235.
   Google Scholar
• Mountain CF., Dressler CM. Regional lymph node classification for lung cancer staging. Chest, 1997, 111: 1718–1723.
   Google Scholar
• Mountain CF. Revisions in the international system for staging lung cancer. Chest, 1997, 111: 1710–1717.
   Google Scholar
• Melek H., Gunluoglu M. z., Demir A., Akin H., Olcmen A., Dincer S. I. Role of positron emission tomography in mediastinal lymphatic staging of non-small cell lung cancer. Eur J Cardio-thorac Surg, 2008, 33: 294–299.
   Google Scholar
• Lee B. E., Redwine J., Foster C. et al. Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3. J Thorac Cardiovasc Surg, 2008, 135: 615619.
   Google Scholar
• Gonzalez-Stawinski G. V., Lemaire A., Merchant F. et al. A comparative analysis of positron emission tomography and mediastinoscopy in staging non-small cell lung cancer. J Thorac Cardiovasc Surg, 2003, 126: 1900–1905.
   Google Scholar
• Al-Sarraf N., Aziz R., Gately K. et al. Pattern and predictors of occult mediastinal lymph node involvement in non-small cell lung cancer patients with negative mediastinal uptake on positron emission tomography. Eur J Cardiothorac Surg, 2008, 33: 104109.
   Google Scholar
• Toloza E. M., Harpole L., Detterbeck F., McCrory D. C. invasive staging of non-small cell lung cancer: a review of the current evidence. Chest, 2003, 123: 157–6.
   Google Scholar
• Verhagen A. F., Bootsma G. P., Tjan-Heijnen V. C. et al. FDG-PET in staging lung cancer: how does it change the algorithm ? Lung cancer, 2004, 44: 175–181.
   Google Scholar
• Lee P C., Port J. L., Korst R. J., Liss Y., Meherally D. N., Altorki N. K. Risk factors for occult mediastinal metastases in clinical stage i non-small cell lung cancer. Ann Thorac Surg, 2007, 84: 177–181.
   Google Scholar
• Cerfolio R. J., Bryant A. S., Eloubeidi M. A. Routine medi-astinoscopy and esophageal ultrasound fine-needle aspiration in patients with non-small cell lung cancer who are clinically N2 negative: a prospective study. Chest, 2006, 130: 1791–1795.
   Google Scholar
• Yasufuku K., Nakajima T., Motoori K. et al. Comparison of endobronchial ultrasound, positron emission tomography, and CT for lymph node staging of lung cancer. Chest, 2006, 130: 710–718.
   Google Scholar
• Rusch V. W., Asamura H., Watanabe H., Giroux D. J., Rami-Porta R., Goldstraw P. The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol, 2009, 4: 568–577.
   Google Scholar
• Lopez L., Varela A., Freixinet J. et al. Extended cervical medi-astinoscopy: prospective study of fifty cases. Ann Thorac Surg, 1994, 57: 555–557.
   Google Scholar
• Call S., Rami-Porta R., Serra-Mitjans M. et al. Extended cervical mediastinoscopy in the staging of bronchogenic carcinoma of the left lung. Eur J Cardiothorac Surg, 2008, 34: 1081–1084.
   Google Scholar
• Lemaire A., Nikolic I., Petersen T. et al. Nine-year single center experience with cervical mediastinoscopy: complications and false negative rate. Ann Thorac Surg, 2006, 82: 1185–1189.
   Google Scholar
• Hammoud z. T., Anderson R. C., Meyers B. F. et al. The current role of mediastinoscopy in the evaluation of thoracic disease. J Thorac Cardiovasc Surg, 1999, 118: 894–899.
   Google Scholar